Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in Rheumatoid Arthritis
NCT04909931Completed
- Sponsor
- Ministry of Public Health
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d in rheumatoid arthritis (RA), sponsored by Ministry of Public Health. Primary endpoint: Disease Activity Score 28-erythrocyte sedimentation rate at 12 weeks. Started May 2021; status: completed.
02
Drugs
vitamin d
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04909931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04909931.